Bronchoscopic Lung Volume Reduction (BLVR): Procedure, Benefits, and Recovery
Updated: 3 days ago
Medically reviewed by Dr. Baraa Alnahhal, MD · Last reviewed: October 2026
Quick Answer
Bronchoscopic lung volume reduction (BLVR) is a non-surgical procedure that improves breathing in people with severe emphysema or COPD. [1] Tiny endobronchial valves placed in the most damaged lung areas let trapped air escape, easing shortness of breath. [1] It typically takes 30 to 60 minutes and can relieve symptoms for two to five years, though it is not a permanent cure. [1]
What the research says
In randomized trials, endobronchial valves improved lung function, breathlessness, and exercise capacity, but raised the risk of collapsed lung and flare-ups. A meta-analysis of 9 randomized trials (1,352 patients; 827 treated with valves and 525 on standard care) found significant gains in FEV1, quality of life (SGRQ), dyspnea score (mMRC), and 6-minute walk distance, and a significant reduction in residual volume. Pneumothorax and exacerbations were significantly more common in the valve group, with no significant difference in mortality. The benefit was shown in people with heterogeneous emphysema and no collateral ventilation (PubMed: Díaz-Miravalls et al., Open Respir Arch, 2025) [2].
A network meta-analysis found valves improved FEV1 but increased pneumothorax and, slightly, mid-term mortality. Across 25 randomized trials (4,283 patients) comparing lung volume reduction procedures, endobronchial valves increased FEV1 by 111.8 mL (95% CrI 92.2–136.2) but raised the risk of pneumothorax (RR 12.75, 95% CrI 5.52–35.48) and mid-term mortality within 6 months (RR 2.06, 95% CrI 1.07–4.36; moderate certainty). The authors called for long-term survival data on bronchoscopic procedures (PubMed: Yamamoto et al., Lung, 2025) [3].
Zephyr valves gave clinically meaningful short-term gains in people without collateral ventilation, with more adverse events. A meta-analysis of randomized trials found Zephyr valves improved FEV1 (mean difference 17.36%, 95% CI 9.28–25.45) and also improved quality of life, walk distance, and residual volume, while the relative risk of pneumothorax was 6.32 (95% CI 3.74–10.67) (PubMed: Labarca et al., Respiration, 2019) [4].
What is bronchoscopic lung volume reduction (BLVR)?
Bronchoscopic lung volume reduction (BLVR), also known as endobronchial valve (EBV) therapy, is a specialized medical intervention for individuals with severe emphysema. [1] Emphysema often leads to “air trapping,” where damaged air sacs prevent old air from leaving the lungs. [1] This overinflation makes it difficult for new, oxygen-rich air to enter, resulting in chronic shortness of breath and fatigue. [1]
BLVR addresses this issue by using a bronchoscope—a thin, flexible tube equipped with a light and camera—to place one-way valves in the airways. [1] These valves are strategically positioned to allow trapped air to exit the overinflated lobes of the lung while blocking new air from entering those specific damaged areas. [1] This allows the healthier portions of the lung to expand and function more effectively, significantly improving overall respiratory efficiency.
Eligibility Criteria
Not every patient with COPD or emphysema is a candidate for BLVR. Healthcare providers use strict criteria to ensure the procedure is safe and likely to be effective.
Eligibility Factor | Requirement |
Age | Typically younger than 75 years old. [1] |
Symptom Severity | Severe shortness of breath despite optimal medication and rehabilitation. [1] |
Lung Condition | Evidence of significant air trapping and overinflated lungs. [1] |
Collateral Ventilation | Must not have air moving between lung lobes outside of normal airways. [1] |
Smoking Status | Must be a non-smoker for at least four consecutive months. [1] |
Rehabilitation | Ability to complete pre-operative and post-operative pulmonary rehab. [1] |
What should you expect during a BLVR procedure?
The BLVR process involves extensive preparation, a precise clinical procedure, and a monitored recovery period to ensure the best possible outcomes for the patient.
Pre-Procedure Testing
Before the procedure, patients undergo a battery of tests to confirm their candidacy and map the lungs for valve placement. These tests typically include high-resolution CT scans to identify the most damaged areas, pulmonary function tests (PFTs) to measure air trapping, and arterial blood gas tests to check oxygen levels. [1] Additionally, a six-minute walk test is often used to establish a baseline for exercise capacity. [1]
During the Procedure
The procedure is performed in a hospital setting, usually under general anesthesia. [1] The clinical steps include:
Anesthesia Administration: The patient is placed under sedation or general anesthesia for comfort and safety.
Bronchoscope Insertion: The physician inserts the bronchoscope through the mouth or nose and down into the airways.
Valve Placement: Approximately four tiny endobronchial valves are placed into the targeted lung lobe. [1]
Completion: Once the valves are secured, the bronchoscope is removed. The entire process generally lasts between 30 and 60 minutes. [1]
What is recovery like after bronchoscopic lung volume reduction (BLVR)?
Recovery from BLVR begins with a mandatory hospital stay, usually lasting at least three days. [1] This period allows healthcare teams to monitor for immediate complications, such as a collapsed lung, which is most likely to occur shortly after the valves are placed.
Following discharge, patients must adhere to a structured recovery plan. This includes starting a post-operative pulmonary rehabilitation program within four to six weeks. [1] This specialized physical therapy helps patients maximize the benefits of their improved lung function. While BLVR is not a cure, many patients report that their quality of life improves significantly for two to five years following the procedure. [1]
What are the risks and safety considerations of BLVR?
BLVR is less invasive than traditional lung volume reduction surgery, but it still carries clinical risks, the most common significant one being a collapsed lung (pneumothorax). Patients and providers must weigh these potential complications against the expected benefits of the procedure.
Potential Complications
The most common significant risk is a pneumothorax (collapsed lung), which occurs when the treated lung lobe shrinks and the remaining healthy tissue expands too quickly. Other risks include:
COPD Flare-ups: Temporary worsening of respiratory symptoms. [1] [2]
Infections: Potential for pneumonia or other airway infections. [1]
Procedure-Related Risks: Reactions to anesthesia, minor bleeding, or heart rhythm issues (arrhythmia). [1]
Valve Issues: The need for valve adjustment, replacement, or removal if they do not function as intended.
Conclusion
Bronchoscopic lung volume reduction offers a vital alternative for patients with severe emphysema who have not found relief through standard medical therapies. By utilizing advanced valve technology, BLVR can significantly reduce shortness of breath and increase the ability to perform daily activities. While it requires careful patient selection and carries specific risks, the potential for a substantial improvement in quality of life makes it a powerful tool in modern respiratory care. Patients should consult with a pulmonologist to determine if they meet the specific eligibility requirements for this intervention.
Frequently Asked Questions
1. Is BLVR a permanent cure for emphysema?
No, BLVR is not a cure. It is a treatment designed to manage symptoms and improve quality of life. The benefits typically last between two and five years.
2. How long is the hospital stay after BLVR?
Patients are usually required to stay in the hospital for a minimum of three days for close monitoring following the procedure.
3. Can the valves be removed?
Yes, one of the primary advantages of BLVR is that the endobronchial valves can be removed or replaced by a physician if necessary.
4. Will BLVR help me live longer?
Current medical evidence suggests that while BLVR significantly improves symptoms and quality of life, it does not necessarily extend a patient's overall life expectancy.
5. What is the main risk of the procedure?
The most common serious risk associated with BLVR is a collapsed lung (pneumothorax), which typically occurs within the first few days after the valves are placed.
6. Do I still need to do pulmonary rehab after the procedure?
Yes, pulmonary rehabilitation is a critical component of the treatment plan and is usually required both before and after the procedure to ensure the best results.
7. Can I have BLVR if I still smoke?
No, patients must be non-smokers for at least four months before they can be considered eligible for the BLVR procedure.
8. How many valves are usually placed?
During a typical BLVR procedure, a physician will place approximately four tiny valves into a single lobe of the lung.
9. Is the procedure performed under anesthesia?
Yes, BLVR is performed in a hospital setting under general anesthesia or deep sedation to ensure the patient remains still and comfortable.
10. When should I call my doctor after the procedure?
Seek immediate medical attention if you experience signs of a collapsed lung or infection, such as sudden chest pain, severe difficulty breathing, fever, or blue-tinted lips and nails.
11. How do I prepare for bronchoscopic lung volume reduction?
Candidacy testing may include blood tests, a chest X-ray, high-resolution CT, pulmonary function tests, an arterial blood gas, an echocardiogram, right heart catheterization and a six-minute walk test [1]. You must not currently smoke, must have stopped for at least four months, and need to complete 6 to 10 weeks of pulmonary rehabilitation before the procedure [1]. Do not eat for eight hours beforehand, tell your provider about all drugs, over-the-counter products and supplements because some may need to be stopped, and plan for a hospital stay of several days with someone to drive you home [1].
Related Reading
Learn more in our guide to Lung Volume Reduction Surgery (LVRS): Who Qualifies, Procedure, Risks and Results.
References
Cleveland Clinic. What Is Bronchoscopic Lung Volume Reduction (BLVR)? Cleveland Clinic. Aug. 22, 2024. https://my.clevelandclinic.org/health/procedures/blvr
Díaz-Miravalls J, Romero-Linares A, Jiménez-Gómez M, et al. Efficacy and safety of bronchoscopic lung volume reduction with endobronchial valves: A systematic review and meta-analysis. Open Respir Arch. 2025;7(3):100443. PMID 40530361. https://doi.org/10.1016/j.opresp.2025.100443
Yamamoto S, Horita N, Imai R, Niitsu T. Surgical and bronchoscopic lung volume reduction for severe emphysema: A systematic review and network meta-analysis. Lung. 2025;203(1):22. PMID 39762564. https://doi.org/10.1007/s00408-024-00777-0
Labarca G, Uribe JP, Pacheco C, et al. Bronchoscopic lung volume reduction with endobronchial Zephyr valves for severe emphysema: A systematic review and meta-analysis. Respiration. 2019;98(3):268-278. PMID 31117102. https://doi.org/10.1159/000499508
Medical Disclaimer
This article is for informational purposes only and does not constitute medical advice. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read here.
Comments